Cameco Corporation provides uranium for the generation of electricity in the Americas, Europe, and Asia. It operates in three segments: Uranium, Fuel Services, and Westinghouse. The Uranium segment engages in the exploration for, mining, milling, purchase, and sale of uranium concentrate. Its Fuel Services segment is involved in the refining, conversion, and fabrication of uranium concentrate, as well as purchase and sale of conversion services. The Westinghouse segment operates as a nuclear reactor technology original equipment manufacturer and a provider of products and services to commercial utilities and government agencies. It also provides outage and maintenance, engineering support, instrumentation and controls equipment, and plant modification services, as well as components and parts to nuclear reactors. The company sells its uranium and fuel products and services to nuclear utilities. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.…
Sprott Asset Management's Jacob White on uranium stocks sell-off and the case for a recovery
Cameco (NYSE: CCJ) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Uranium industry, part of the Energy sector.
The shares were at 57.99 USD on 20 November 2026, down 32.6% over 52 weeks. Its 52-week range is 57.88 USD to 135.24 USD, and it trades at the bottom of that range.
At a market capitalisation of 25.26B USD, it trades at 87.9 times trailing earnings and 33.9 times forward earnings. The median trailing P/E of its 7 largest Uranium peers is 24.2, a premium of 264% for CCJ. It pays a dividend yielding 0.27% (it pays out 26% of its earnings).
Cameco reports return on equity of 8.5%, an operating margin of 12.9% and revenue up 0.7% year over year.
Its debt exceeds its cash by 149.22M CAD, a debt-to-equity ratio of 0.14. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 9 analysts cover the stock, with an average rating of Buy; their mean price target of 115.18 USD is 98.6% above the current price. The next earnings report is expected on 12 February 2027.